1. Guidance for Industry, Q3B Impurities in New Drug Products;U.S. Food and Drug Administration,2006
2. Stress testing: a predictive tool;Baertschi,2005
3. Stress testing: analytical considerations;Jansen,2005
4. Analysis of impurities and degradants in pharmaceuticals by high resolution tandem mass spectrometry and on-line H/D exchange LC/MS;Chen;Am. Pharm. Rev.,2010
5. Identification and characterization of a photolytic degradation product of telmisartan using LC–MS/TOF, LC–MSn, LC–NMR and on-line H/D exchange mass studies;Shah;J. Pharm. Biomed. Anal.,2010